Northland Securities initiated coverage on shares of Olaplex (NASDAQ:OLPX – Free Report) in a research note published on Thursday morning, Marketbeat reports. The firm issued an outperform rating and a $2.00 price objective on the stock.
Several other equities research analysts have also commented on OLPX. Weiss Ratings restated a “sell (d)” rating on shares of Olaplex in a research note on Wednesday, October 8th. Barclays decreased their target price on Olaplex from $1.50 to $1.25 and set an “equal weight” rating for the company in a report on Monday, November 10th. Zacks Research lowered shares of Olaplex from a “hold” rating to a “strong sell” rating in a report on Monday, October 27th. Canaccord Genuity Group raised shares of Olaplex from a “hold” rating to a “buy” rating and lifted their price target for the company from $1.50 to $2.00 in a research report on Monday, August 25th. Finally, Telsey Advisory Group reissued a “market perform” rating and issued a $2.00 price objective on shares of Olaplex in a research report on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $1.85.
Read Our Latest Stock Analysis on OLPX
Olaplex Price Performance
Olaplex (NASDAQ:OLPX – Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.02 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.02. The company had revenue of $114.58 million for the quarter, compared to analyst estimates of $109.77 million. Olaplex had a negative net margin of 1.18% and a positive return on equity of 1.31%. Olaplex’s revenue for the quarter was down 3.8% on a year-over-year basis. During the same quarter last year, the business earned $0.04 EPS. Olaplex has set its FY 2025 guidance at EPS. Sell-side analysts predict that Olaplex will post 0.1 earnings per share for the current year.
Institutional Investors Weigh In On Olaplex
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. R Squared Ltd acquired a new position in Olaplex in the 2nd quarter worth $25,000. Chilton Capital Management LLC purchased a new stake in shares of Olaplex during the third quarter worth about $26,000. Schonfeld Strategic Advisors LLC purchased a new stake in shares of Olaplex during the third quarter worth about $30,000. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Olaplex in the third quarter worth about $32,000. Finally, BNP Paribas Financial Markets raised its position in shares of Olaplex by 95.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 29,707 shares of the company’s stock valued at $39,000 after purchasing an additional 14,507 shares in the last quarter. Hedge funds and other institutional investors own 87.37% of the company’s stock.
Olaplex Company Profile
Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.
Further Reading
- Five stocks we like better than Olaplex
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Big Tech Stocks Sliding: What’s Behind the Drop?
- Compound Interest and Why It Matters When Investing
- Wall Street Sees a Winner in Take-Two Stock. Should You?
- What Investors Need to Know About Upcoming IPOs
- Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.
